CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.41
-0.02 (-0.37%)
At close: Jul 1, 2025, 4:00 PM
5.47
+0.06 (1.11%)
After-hours: Jul 1, 2025, 7:48 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $1.22 billion as of July 1, 2025. Its market cap has increased by 35.77% in one year.
Market Cap
1.22B
Enterprise Value
784.82M
1-Year Change
35.77%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.22B, a decrease of -87.62%. That is a compound annual growth rate of -34.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 1.22B | 59.26% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |